Enfusion, Inc. (ENFN)
Apr 21, 2025 - ENFN was delisted (reason: acquired by CWAN)
10.76
0.00 (0.00%)
Inactive · Last trade price on Apr 17, 2025

Enfusion Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec '24 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
201.61201.61174.54150.35111.779.57
Revenue Growth
15.51%15.51%16.09%34.60%40.39%34.79%
Gross Profit
136.74136.74116.89103.2579.8658.21
Operating Income
6.166.1611.95-11.96-275.886.07
Net Income
2.822.826.33-8.61-187.794.06
Earnings Per Share
0.030.030.07-0.10-2.2684.66
EPS Growth
-57.73%-57.73%----

Cash & Debt

Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec '24 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Investments
54.4854.4835.662.5564.3713.94
Total Debt
20.3120.3115.446.99-98.56
Net Cash (Debt)
34.1734.1720.1755.5664.37-84.63
Net Cash Growth
69.42%69.42%-63.70%-13.69%--
Net Cash Per Share
0.260.260.160.650.78-1764.20

Cash Flow & CapEx

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec '24 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Cash Flow
34.6834.6825.6314.16-0.321.67
Capital Expenditures
-3.64-3.64-4.45-3.99-6.1-5.07
Free Cash Flow
31.0531.0521.1810.17-6.41-3.4
Free Cash Flow Growth
46.58%46.58%108.25%---

Margins

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec '24 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Gross Margin
67.82%67.82%66.97%68.67%71.49%73.16%
Operating Margin
3.05%3.05%6.85%-7.96%-246.99%7.63%
Pretax Margin
3.66%3.66%6.58%-8.11%-252.16%5.65%
Profit Margin
1.40%1.40%3.63%-5.73%-168.12%5.10%
FCF Margin
15.40%15.40%12.14%6.77%-5.74%-4.28%

Valuation

Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingAug '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PE Ratio
356.07344.33135.26---
Forward PE
37.3538.4543.5269.0785.47-
P/FCF Ratio
44.7131.3140.4365.59--
PS Ratio
4.914.824.914.4412.30-